Fifty % of the infants will be monitored by specialists and referred for community treatment. The various other infants and their mothers will participate in an intervention at the UW Autism Center that promotes first interactions. Mothers will learn to activate their infants in vision contact and each mother and child will be videotaped interacting once a week for nine weeks. All of the small children in both groups will be evaluated when they are 12 a few months old. Those in the UW treatment group then will participate in an early on intensive intervention program. At 24 months, the small children will be re-evaluated to see if the intervention reduces the outward symptoms of autism.The Company delivers upon this promise with safe, innovative and effective allografts. ‘It really is with great satisfaction that we are again called a CEBA finalist, because living our objective is at the primary of what we do,’ said Thomas Cycyota, AlloSource President and CEO. ‘We strive to be considered a trusted, valued, educated partner to the medical community aswell as to patients and donor households, and our associates are instrumental in making that happen every full day.’ In 2008, AlloSource saved and improved the lives of more folks in more communities than previously.